IDARUBICIN EBEWE Australia - English - Department of Health (Therapeutic Goods Administration)

idarubicin ebewe

sandoz pty ltd - idarubicin hydrochloride -

Idarubicin hydrochloride Injection 20 mg in 20 mL (2) Australia - English - Department of Health (Therapeutic Goods Administration)

idarubicin hydrochloride injection 20 mg in 20 ml (2)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - idamycin pfs injection in combination with other approved anti leukemic drugs is indicated for the treatment of acute myeloid leukemia (aml) in adults. this includes the french-american-british (fab) classifications m1 through m7.

Idarubicin hydrochloride Injection 10 mg in 10 mL (2) Australia - English - Department of Health (Therapeutic Goods Administration)

idarubicin hydrochloride injection 10 mg in 10 ml (2)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - idamycin pfs injection in combination with other approved anti leukemic drugs is indicated for the treatment of acute myeloid leukemia (aml) in adults. this includes the french-american-british (fab) classifications m1 through m7.

Idarubicin hydrochloride Injection 5 mg in 5 mL (2) Australia - English - Department of Health (Therapeutic Goods Administration)

idarubicin hydrochloride injection 5 mg in 5 ml (2)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - idamycin pfs injection in combination with other approved anti leukemic drugs is indicated for the treatment of acute myeloid leukemia (aml) in adults. this includes the french-american-british (fab) classifications m1 through m7.

Idarubicin Injection 10 mg/10 mL (3) Australia - English - Department of Health (Therapeutic Goods Administration)

idarubicin injection 10 mg/10 ml (3)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: glycerol; hydrochloric acid; water for injections - south africa: acute non-lymphocytic leukaemia (anll), including acute myeloblastic leukaemia (aml) in adults, for remission induction as front-line therapy, or for remission induction in relapsed or refractory patients. zavedos, in combination with cytarabine, is indicated for the first remission induction-line treatment of previously untreated children with acute myeloid leukaemia (aml)

Idarubicin Injection 5 mg/5 mL (3) Australia - English - Department of Health (Therapeutic Goods Administration)

idarubicin injection 5 mg/5 ml (3)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: glycerol; hydrochloric acid; water for injections - south africa: acute non-lymphocytic leukaemia (anll), including acute myeloblastic leukaemia (aml) in adults, for remission induction as front-line therapy, or for remission induction in relapsed or refractory patients. zavedos, in combination with cytarabine, is indicated for the first remission induction-line treatment of previously untreated children with acute myeloid leukaemia (aml)

Idarubicin Injection 5 mg/5 mL (5) Australia - English - Department of Health (Therapeutic Goods Administration)

idarubicin injection 5 mg/5 ml (5)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - acute myeloid leukaemia in combination with other cytotoxic agents. acute lymphoblastic leukaemia as a reserve medicinal product in combination with other cytotoxic agents.

Idarubicin Injection 5 mg/5 mL (4) Australia - English - Department of Health (Therapeutic Goods Administration)

idarubicin injection 5 mg/5 ml (4)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - taiwan acute non-lymphatic leukaemia (anll) in adults. acute lymphatic leukaemia (all) in adults and children

Idarubicin Injection 10 mg/10 mL (5) Australia - English - Department of Health (Therapeutic Goods Administration)

idarubicin injection 10 mg/10 ml (5)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - brunei darussalam and malaysia: antimitotic and cytotoxic agent. acute non-lymphocytic leukemia (anll) in adults for remission induction in untreated patients or for remission induction in relapsed or refractory patients. acute lymphocytic leukemia (all) as second line treatment in adults and children.

Idarubicin Injection 10 mg/10 mL (4) Australia - English - Department of Health (Therapeutic Goods Administration)

idarubicin injection 10 mg/10 ml (4)

pfizer (perth) pty ltd - idarubicin hydrochloride, quantity: 1 mg/ml - injection, solution - excipient ingredients: glycerol; hydrochloric acid; water for injections - zavedos is used to treat acute myeloid and lymphoid leukaemia (types of blood cancer) in adults and children. zavedos may be administered as a monotherapy or as part of combination therapy (with cytarabine).